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ABSTRACT
Non-enzymatic vitamin C (ascorbic acid) plays an important role in the medicinal field and acts as antioxidants use in fruits and vegetable such as 
lemon, orange, grapes, carrots, tomatoes, grapefruit, beans, broccoli, and mangos. It helps to prevent and stop of various diseases such as lung cancer, 
asthma, and wheezing and finding an antibronchospastic effect. Other factors such as diet have also been implicated in the development of lung 
cancer. Despite the extensive research conducted in this area, the relationship between diet and lung cancer is still not clear. Diets high in fat and 
low in vegetables and fruits may increase the risk of lung cancer and other fact eating of tobacco and smoking of cigarette. Lung tissue damage due 
to high levels of free radicals in cigarette smoke causes direct (tissue oxidation) and indirect (release of oxidizing agents and enzymes). Vitamin C is 
necessary for phagocytosis. It plays a significant role in daily life, dietary system like eating food, vegetable and smoking of cigarette. It helps to prevent 
or stop the damage the lung tissue/or cause lung cancer. The present review studied that application of vitamin C act as antioxidant in lung cancer like 
diseases such as lung-cancer and role in lung function.
Keywords: Review, Non-enzymatic antioxidant (vitamin C), Lung function, Lung diseases.
BACKGROUND
Since an early 18th and/or 20th century research on these compounds 
run to the discovery of vitamins:
1747 - Lind cured scurvy in British sailors with oranges and lemons.
1907 - It is reproduced experimental scurvy in guinea pigs.
1928 - Eascott identified bios-I as meso-inositol. Szent-Gyorgy and Glen 
published the isolation of vitamin C or hexuronic acid.
1933 - Allison, Hoover, and Burk describe a compound that promotes 
the respiration and growth of rhizobium, which designated 
“Coenzyme R.” Then, it is defined the molecular structure and 
synthesis of vitamin C.
1937 – For the determining the structure of ascorbic acid scientist 
“Walter Haworth” was awarded a Nobel Prize in chemistry to for his 
work.
1981 - Bergman et al. effect of vitamin C on bile acid pattern.
Chemistry of vitamin C
The structure of vitamin C (ascorbic acid) (Fig. a): Vitamin C is 
five member oxygen-containing cyclic organic compound. Oxygen 
containing an electron donar, and it reacted with base and abstracted 
proton and becomes to more nucleophilic in nature. The isomeric 
form (Fig. b) and act as nucleophilic in nature. It reacts with base gives 
ascorbate ion then speedy react with electrophile (Fig. c).
Acidity
At different levels of vitamin C, it gives different hydrogen ion 
concentrations; at pH 7.4, 99.95% of vitamin C will be present as AscH−; 
0.05% as AscH2, and 0.004% as Asc2−. Thus, the antioxidant chemistry 
of vitamin C is the chemistry of AscH− (Fig. d).
Review Article
Fig. a: Ascorbic acid
Fig. b: Isomeric form of vitamin C
Fig. c: Electrophilic reaction of vitamin C
Fig. d: Acidity in different condition of vitamin C
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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INTRODUCTION
An essential dietary component vitamin C, also known as L-ascorbic 
acid (hexuronic acid, cevitaminic acid, or xiloascorbic acid) (Fig. 1), is 
a water-soluble vitamin that is naturally present in some foods, added 
to others, and available as a dietary supplement. Humans, unlike most 
animals, are unable to synthesize vitamin C endogenously [1].
Vitamin C is one of the most common antioxidants in fruits and vegetables, 
and it may exert chemopreventive effects [2], play a role in lung function and 
wheezing [2]. It has generally been acknowledged that vitamin C protects 
cells from oxidative DNA damage, thereby blocking carcinogenesis [3]. 
The role of ascorbic acid (vitamin C) in asthma has long been argued, 
early as 1803 Reisseissen suggested that vitamin C prevents the wheezing 
observed in patients with diseases scurvy [4]. More recently, animal 
studies have shown that ascorbic acid may prevent anaphylaxis and other 
allergic phenomena [5,6]. In guinea pigs, ascorbic acid has been shown 
to reduce the airway obstruction prompted by 5-hydroxytryptamine, 
bradykinin, and histamine [7]. In healthy human subjects demonstrated 
that vitamin C inhibits histamine-induced bronchospasm [8]. These 
findings suggest that vitamin C may have an antibronchospastic effect, 
although some authors have failed to find evidence to support these 
results [9,10]. To further study the potential role of ascorbic acid in 
patients with asthma, we investigated the effect of vitamin C on exercise-
induced bronchospasm, a common asthmatic syndrome that can be easily 
reproduced under controlled laboratory conditions [11].
Vitamins and lung cancer [11]: Lung cancer is the most common cancer 
in the world. In the year 1996, an estimated 1·3 million new cases 
were diagnosed worldwide accounting for 12.8% of all new cases of 
cancer (World Cancer Research Fund and American Institute for Cancer 
Research, 1997). Prevention, detection, and early treatment are the 
tools to reduce lung cancer morbidity and mortality. Early detection of 
lung cancer has not been successful, as symptoms often do not appear 
until the disease is advanced. Similarly, screening of asymptomatic 
subjects with regular chest X-rays or sputum cytology has not been 
successful. Despite advances in the treatment of lung cancer, the 5-year 
survival for lung cancer is only 10-15%. Thus, the only efficient way to 
reduce the burden from lung cancer is prevention.
Smoking of cigarette is the predominant risk factor for lung cancer; 
about 90% of the cases are attributable to cigarette smoking. Other 
risk factors for lung cancer include passive smoking, asbestos, radon, 
chemical carcinogens, previous chronic inflammatory lung disease, and 
genetic predisposition. Diet has also been implicated in the development 
of lung cancer. Despite the extensive research conducted in this area, 
the relationship between diet and lung cancer is still not clear. Diets 
high in fat and low in vegetables and fruits may increase the risk of 
lung cancer [11]. The specific mechanisms of the interaction between 
diet and lung cancer remain to be elucidated. As the worldwide lung 
cancer cause due to various polluted and/or deficiency dietary food and 
vegetable for the year 2011-2016 were increased (Fig. 2).
The number of epidemiologic studies has been published exploring 
the relationship between vitamin C intake and lung cancer risk (Fig. 3). 
The result of these studies are not consistent and a meta-analysis to: 
(1) Assess lung cancer risk for the highest versus lowest categories 
of vitamin C intake; (2) assess the dose-response association of lung 
cancer for every 100 mg/day increment in vitamin C intake; (3) assess 
heterogeneity and publication bias among the studies analyzed [12]. 
The cancer-related deaths worldwide, furthermore, the overall survival 
rate for lung cancer patients is extremely low [13] such as lung cancer.
An account for a significant amount of the age-adjusted incidence 
rate of lung cancer was recently reported at 62.6 cases/100,000 
pessople/year, and the age-adjusted death rate at 50.6 per 100,000 
people/year [14]. Thus, primary prevention of lung cancer is serious. 
Many studies have shown that lung cancer is associated with genetic 
factors [15,16] and environmental factors including tobacco use [17], 
alcohol consumption [18], and intake of fruit, vegetables [19], and 
vitamins [20,21] can also affect the incidence of lung cancer. The work 
influence that dietary factors may have upon the occurrence of this 
neoplasm and on the causes of possible effect [22]. Increased cancer 
mortality risks associated with low plasma cholesterol were not 
explained by the confounding effect of antioxidant vitamins but were 
attributed in part to the effect of preexisting cancer [23]. High levels 
of free radicals in cigarette smoke (CS) cause direct (tissue oxidation) 
and indirect (release of oxidizing agents and enzymes) damage to lung 
tissue [24]. About the diet, several cross-sectional epidemiological 
studies have suggested that dietary antioxidants and foods rich in 
antioxidants (i.e., fruit and vegetables) may protect the airways against 
oxidant-mediated damage leading to chronic obstructive airways 
disease (COPD) [25]. Only three longitudinal studies on the relation 
between diet and COPD-related outcomes have been published. In the 
Zutphen study, an inverse relationship was observed between baseline 
consumption of total and solid (¼ apples, pears) fruit and 25-year 
incidence of chronic lung disease [26]. To observe a relationship with 
intake of antioxidant Vitamin C and β-carotene, follow-up in the other 
two studies was relatively duration 5-7 year [27]. Non-statistically 
significant longitudinal relationship between vitamin C and E or apple 
intake with pulmonary function. However, baseline apple consumption 
did tend to be inversely related to change in forced expiratory 
volume 1 [28]. In addition to the above-mentioned dietary factors with 
antioxidant capacities, a protective effect against the development of 
COPD has been suggested for fish consumption. Fish oils are thought 
to have anti-inflammatory effects because of the influence of the 
polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic 
acid on arachidonic acid metabolism [29]. The cross-sectional studies 
published in 1990 and 1994 suggested an inverse association between 
Fig. 1: Ascorbic acid in food and vegetable
Fig. 2: Worldwide; lung cancer increase between 5 year
Fig. 3: Lung cancer; intake vitamin C
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fish consumption and COPD-related outcomes [30]. However, all cross-
sectional studies published in later years reported negative findings [31], 
no association of fish consumption with 25-year incidence of chronic 
lung disease was observed [32].
MECHANISM AND/OR ROLE OF ANTIOXIDANTS
Antioxidant system available to cells during oxidative stress is that 
of free-radical-scavenging agents. It is the first line of defense against 
oxygen free radicals damaging to cellular components and contributing 
to inflammation. In short, these agents are present to varying degrees 
in the intracellular and extracellular spaces, and they function by either 
eliminating oxidants or preventing their conversion to more toxic 
compounds. Normally, the lung exists in an oxygen-rich environment 
generated through normal cellular function or exposure to pro-oxidants 
and the protective activities of several intracellular and extracellular 
antioxidant defense systems. A tight control of redox balance is critically 
important for the maintenance of normal pulmonary cellular function [33]. 
A shift of the oxidant/antioxidant balance in favor of oxidants has been 
termed “oxidative stress” [34]. Researchers have hypothesized that a 
diet low in antioxidants such as 3-carotene, vitamins C and E may reduce 
natural defenses and increase susceptibility to oxidant attack and airway 
inflammation [33]. CS and atmospheric pollutants such as ozone (O3) and 
nitrogen oxide (NO) are rich in free radicals and exposure to them can 
induce oxidant-mediated lung injury by direct tissue oxidation, as well as 
through endogenous oxidizing agents and proteolytic enzymes released 
after recruitment and activation of neutrophils during the inflammatory 
response [35]. Inhaled oxidants also amplify the effect of neutrophil 
proteases by oxidative deactivation of 1-proteinase inhibitor [33-36]. 
The antioxidant defenses of the lung have been reviewed [33,35,36]. 
Antioxidants may act at different levels in the oxidation process, for 
examples, by scavenging initiating radicals, binding metal ions, by 
scavenging peroxyl radicals, or by removing oxidatively damaged 
biomolecules [34]. Antioxidant defenses in the lung are provided by 
endogenous enzyme systems and non-enzymatic antioxidant compounds. 
The major enzymatic antioxidants are superoxide dismutase, which 
degrades superoxide anion, and catalase and the glutathione redox system, 
which inactivates hydrogen peroxide (H2O2). The antioxidant defenses of 
the lung have been reviewed [37-39]. Non-enzymatic antioxidants such 
as vitamin E (tocopherol), vitamin C (ascorbic acid), and β-carotene (a 
precursor of vitamin A) Fig. 4, ubiquinone, flavonoids, and selenium are 
present in foods and are considered dietary antioxidants [33]. Vitamin E, 
a lipid-soluble vitamin, represents the body’s principal defense against 
oxidant-induced membrane injury in human tissue, via its role in breaking 
the lipid peroxidation chain reaction [40]. Water-soluble vitamin C, 
contributes to antioxidant activity through several mechanisms, including 
scavenging the superoxide radical O2~. Vitamin C acts on airways by 
affecting arachidonic acid metabolites, particularly prostaglandins. 
Vitamin C appears to be the most abundant antioxidant substance in 
the extracellular fluid lining of the lung [41], and it also contributes to 
the regeneration of membrane-bound oxidized vitamin E, allowing it to 
function again as a chain-breaking antioxidant [42]. In addition, vitamin 
C plays a role in immune function and is transported into neutrophils and 
lymphocytes [36]. β-carotene, a precursor to vitamin A, accumulates in 
tissue membranes, scavenges superoxide anion, and reacts directly with 
peroxyl free radicals, thereby serving as a lipid-soluble antioxidant [33].
Thus, dietary intake of these vitamins may play a role in host defense 
against oxidative lung damage. Flavonoids such as quercetin (Fig. 5) are 
scavengers of superoxide anion; they exhibit singlet oxygen-quenching 
proprieties, scavenge lipid peroxyl radicals, and can act as chelators of 
iron (Fe) ions [33]. Selenium (Se) is incorporated into the antioxidant 
enzyme glutathione peroxidase, which reduces H2O2 and other organic 
peroxides, thereby preventing lipid peroxidation and subsequent in 
stability of cell membranes. Antioxidant intake may act primarily on 
the evolution of asthma, modulating the impact of oxidants on the lung, 
decreasing inflammation of the airway. Infection and inhaled pollutants 
activate leukocytes to produce oxidants. Neutrophils, eosinophils, and 
alveolar macrophages from asthmatic patients produce more reactive 
oxygen species than do those from normal subjects. Reactive oxygen 
species directly contract airway smooth muscle preparation [42] and 
can stimulate histamine release from mast cells [41]. A number of 
antioxidant disturbances have also been observed in COPD patients, 
increase in lipid peroxidation products, and DNA damage. The 
Oxidative stress in chronic obstructive pulmonary disease, nutrition 
and metabolism of trace elements and reactive oxygen species and 
airway inflammation with clinical action[37, 43, 44]. Fresh fruits and 
vegetables contain considerable amounts of vitamin C (e.g., broccoli, 
spinach, tomatoes, and citrus fruits) and carotenoids (e.g., carrots, 
tomatoes, grapefruit, beans, broccoli, oranges, and mangos) [45]. The 
main carotenoids serving as provitamin β-carotene and cryptoxanthin 
may be transformed into vitamin A. The richest sources of vitamin E 
in the human diet are oil products such as mayonnaise, vegetable and 
seed oils (corn, safflower, and soybean), butter, and eggs. Flavonoids are 
mainly found in fruits and vegetables (apples, lemons, oranges, potatoes, 
and cauliflower) and tea [33]. The current recommended dietary 
allowance requirements are 60 mg/day for vitamin C (100 mg/day for 
smokers), 800-1000 retinol equivalents per day (1 retinol equivalent = 6 
(i.e., of β-carotene) for vitamin A, and 55-70 u.g/day for selenium [46].
Vitamin C contributes to antioxidant activity through several other 
mechanisms. It does so primarily by scavenging O2, but it also contributes 
to the regeneration of membrane-bound oxidized vitamin E, allowing it 
to function again as a chain-breaking antioxidant [47]. Dietary intake of 
these vitamins may, therefore, play a role in the host’s defense against 
oxidative cell and lung damage, the oxidation of ascorbic acid using the 
oxidation of ascorbic acid by generate in situ H2O2 (hydrogen peroxide) 
to the dehydro ascorbate cell damage to dehydration by catalyse (Fig. 6).
Fig. 4: Non-enzymatic antioxidants: vitamin E (α-tocopherol), 
vitamin C (ascorbic acid), and β-carotene
Fig. 5: Chemical structure of flavonoids-quercetin
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VITAMIN C
Intake of vitamin C vegetables and fruits having shown six prospective 
studies the association between these indices and lung cancer 
risk [48]. The results have varied from an inverse association to 
no association [49a-g], but three of the most recent reports have 
demonstrated a significant inverse association between dietary vitamin 
C and the risk of lung cancer [50a-c]. An association between plasma 
ascorbic acid concentration and lung cancer risk has been reported in 
two studies; in one study, plasma ascorbic acid was not predictive of 
subsequent lung cancer [51]; in another study, a modest non-significant 
protection was noted [52]. No controlled trials of supplementation with 
vitamin C in relation to lung cancer have been published.
Lung cancer: Tomato and/or tomato-based food-vitamin C as 
containt
A several studies view has reported an inverse association between tomato 
and/or lycopene intake and the risk of some types of cancer. In 2004, 
Food and Drug Administration (FDA) received two petitions for qualified 
health claims regarding tomatoes, lycopene, and the risk reduction for 
some forms of cancer. Here, we describe FDA’s review of the scientific 
data for tomato and/or lycopene intake with respect to risk reduction for 
certain forms of cancer. The FDA found no credible evidence to support an 
association between lycopene intake and a reduced risk of prostate, lung, 
and colorectal, gastric, breast, ovarian, endometrial, or pancreatic cancer. 
The FDA also found no credible evidence for an association between 
tomato consumption and a reduced risk of lung, colorectal, breast, 
cervical, or endometrial cancer [53]. The FDA found very limited evidence 
to support an association between tomato consumption and reduced 
risks of prostate, ovarian, gastric, and pancreatic cancers. FDA identified 
18 observational studies on tomato and/or tomato-based food intake and 
the risk of lung cancer including three prospective cohort studies [54-56], 
two nested case-control studies [57,58], one case-cohort study [59], 
and 12 case-control studies [60-69]. Six studies [60-63,70,71] were 
not reviewed further. Of the 12 remaining studies, two studies [72,73] 
included subjects who were not pertinent to the general US population 
(i.e., tin miners from China), these studies pointed out that these subjects 
had unique environmental exposures (i.e., arsenic and severe pollution) 
that increased the incidence of lung cancer, and thus, their findings 
were not generalizable to a general population of the United States [72]. 
Further evaluation of the 10 remaining studies revealed that seven case-
control studies [74-80] included a greater proportion of smokers among 
the case patients than among the control subjects and reported results 
that were not stratified by smoking status. Because smoking causes 
lung cancer [81,82] and can lead to many dietary changes, including 
decreased weight and appetite [83], which may affect food intake and 
could have biased the results of these studies, it was not possible to 
determine whether differences in the consumption of tomatoes and/or 
tomato-based foods contributed independently to the results in the lung 
cancer case patients. Therefore, FDA concluded that scientific conclusions 
about the relationship between tomatoes and tomato-based food 
consumption and lung cancer risk could not be drawn from these seven 
studies, remaining three studies [84-86] were observational studies that 
evaluated the relationship between tomato consumption and lung cancer 
risk and had a high to moderate methodologic quality rating. The cohort 
of 89 284 nurses for approximately 16 years and identified 593 cases of 
lung cancer [84]. They found that eating one or more servings of tomatoes 
per day was not associated with lung cancer incidence [85], analyzed a 
case-cohort of 2814 female control subjects and 138 female case patients 
from Iowa to evaluate tomato intake and lung cancer risk. They found that 
tomato intake was not associated with lung cancer risk [86] conducted 
a nested case-control study that included a case-cohort study with 2953 
control subjects and 1010 case patients from Netherlands. They observed 
no association between raw tomato consumption (25 g/day) and lung 
cancer risk. On the basis of its evaluation of these three reports, FDA 
concluded that there was no credible evidence supporting an association 
between tomato or tomato-based food consumption and lung cancer risk.
Tomatoes and cancer risk reduction
The FDA literature review on tomato consumption and cancer risk 
reduction; none was an interventional study that evaluated tomato 
consumption in subjects who had not been diagnosed with cancer [87].
A total of 64 observational studies of the association between tomato 
or tomato product consumption and cancer risk were identified. Of 
these, 25 [86,88-109] were not reviewed further because they were a 
republication or reanalysis of data that were already used to evaluate 
the health claim and/or because they had scientific deficiencies that 
prevented FDA from drawing scientific conclusions from the study 
(Table 1). For example, studies that measured biomarkers that had not 
been previously validated for the specific cancer under study (e.g., serum 
level of insulin-like growth factor and cervical dysplasia) [110,111] 
were excluded because they did not provide reliable evidence for risk 
reduction, and therefore, no scientific conclusions could be drawn from 
them for the evaluation of a qualified health claim about cancer. Studies 
for which no information was provided about the validation of the food 
frequency questionnaire used were also excluded because failure to 
validate a food-frequency questionnaire may lead to false conclusions 
about associations between dietary factors and disease risk [112,113]. 
To provide no information on the accuracy of measuring tomato 
intake, and hence, no scientific conclusions could be drawn from them 
for the evaluation of a qualified health claim. One study [114] was 
excluded because it lacked a statistical analysis of the data, which 
prevented FDA from determining if there was a difference in cancer 
risk between subjects who did and did not consume tomatoes. Finally, Fig. 6: Cell damage by oxidized ascorbic acid





No information on the validation of 
the food frequency questionnaire
No statistical 
analysis
No calculation of 
risk
Norrish, 2000 (20); 
Tzonou, 1999 (108); 
Garcia-Closase, 1998 (32); 
Giovannucci, 1995 (109); 
La Vecchia, 1987 (110)
Mucci, 2001 (111); de 
Vet, 1991 (112)
Seow, 2002 (113); Brennan, 
2000 (114); Norrish, 2000 (20); 
Cohen, 2000 (21); Mayne, 1994 (115); 
Franceschi, 1994 (116); Levi, 
1993 (117); Ramon, 1993 (118); 
Fraser, 1991 (119); Hu, 1991 (120); 
Bond, 1987 (121); Tuyns, 1988 (122); 
Tajima, 1985 (123); Kvale, 1983 (124); 
Haenszel, 1972 (125)
Boeing, 1991 (126) Baghurst, 
1991 (127); Graham, 
1991 (128); Marshall, 
1983 (129)
aStudies are listed by first author, year of publication (reference). FDA: Food and Drug Administration
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three studies [115-117] were excluded because they did not calculate 
a risk ratio, which made it impossible to determine if tomato intake 
reduced the risks of the cancers under study. Here, the FDA’s reviews of 
the remaining 39 observational studies for a qualified health claim for 
tomatoes and tomato products by cancer type.
VITAMIN CONTRIBUTING: EFFECT AND PLASMA CHAIN-BREAKING 
ANTIOXIDANTS
The study complications of prematurity to result from free radical 
generation and an inadequacy of antioxidative capacity. The plasma 
total peroxyl radical-trapping capability (TRAP) and concentrations of 
the main chain-breaking antioxidants contributing to it, i.e., uric acid, 
ascorbic acid, α-tocopherol, protein sulfhydryl groups, and bilirubin, in 
21 preterm infants with a mean birth weight of 1440 g and gestational 
age of 30 weeks. The infants were divided into two groups according to 
their short-term outcome; the good outcome group (GOG) (n=11) with 
no signs of morbidity and the poor outcome group (POG) (n=10) with 
intraventricular hemorrhage and/or bronchopulmonary dysplasia and/
or retinopathy. Arterial blood samples were obtained 3 and 10 days 
postpartum. TRAP was measured with a chemiluminescent method. 
As a comparison, venous blood samples from 13 adults (aged from 18 
to 34) were used. At day 3, the POG had significantly higher TRAP than 
the good outcome or control group, mainly because of elevated uric 
acid concentration. Furthermore, the concentration of unidentified 
antioxidants was significantly lower in GOG. By day 10, the TRAP 
decreased substantially in both groups. However, from the components 
of TRAP, both ascorbate and the unidentified fraction decreased more 
in POG (p=0.017 and 0.021, respectively). Furthermore, in POG on day 
10, urate concentration did not significantly differ from day 3 values. 
Plasma chain-break antioxidants in preterm infants with good and 
poor short-term outcome [118]. Some of the dietary and lung function: 
Smoking-environmental tobacco smoke decreases some plasma 
antioxidants and increases γ-tocopherol in vivo after adjustment for 
dietary antioxidant intakes [119-121]; Active and passive smokers are 
exposed to reactive free radicals that are present in CS [119]. Because 
free radicals cause oxidative damage to macromolecules such as lipids, 
proteins, and DNA, they are believed to be involved in the pathogenesis of 
cardiovascular diseases and cancer [120-122]. Free radicals in CS deplete 
some plasma antioxidants in vitro [122,123], and several studies found 
lower plasma antioxidant concentrations in smokers in vivo [124-130]. 
Less information is available on the effect of CS exposure on plasma 
antioxidant concentrations in passive smokers [131-135]. It has been 
difficult to determine whether differences in plasma antioxidants 
between smokers and non-smokers are actually due to the effect of CS 
exposure or are due instead to differences in dietary antioxidant intakes 
or in other covariates. Epidemiologic studies showed that CS consume 
fewer fruits and vegetables than do non-smokers [136-140]. In addition, 
CS consume fewer vitamin supplements than do non-smokers [141-145]. 
The dietary habits of passive smokers were found to be intermediate 
between those of smokers and non-smokers [144]. As a result, the in 
vivo effect of smoking or passive smoking on plasma antioxidant status 
remains unclear. The study confirmed active smoking, passive smoking, 
or non-smoking status with plasma cotinine measures, excluded 
current or recent vitamin supplement users, and adjusted for dietary 
antioxidant intakes and other covariates. This permitted us to examine 
the effect of active and passive smoking on several plasma antioxidants, 
unconfounded by other factors. Non-smokers and passive smokers have 
antioxidant concentrations that are between those of smokers and non-
smokers. These results indicate that CS and non-smokers exposed to CS 
have a significantly lower plasma antioxidant status than do unexposed 
non-smokers, independent of differences in dietary antioxidant intakes. 
Further research is required to explain why plasma γ-tocopherol 
concentrations were significantly higher in smokers and passive smokers 
than in non-smokers [144].
STUDY OF BLOOD VITAMIN C IN LUNG AND BLADDER CANCER 
PATIENTS BEFORE AND AFTER TREATMENT WITH ASCORBIC ACID
A systematic study of vitamin C blood levels in patients with cancer and 
an evaluation of their modifications when the patients were orally treated 
with daily large doses of ascorbic acid (5 g/day) have been carried out. 
For excluding any interference on intestinal vitamin C absorption, all 
patients with digestive tract cancer have been excluded. The study has 
shown hypo vitaminosis C subclinical conditions for the greater part of 
subjects: In fact, the average hematic rate of ascorbic acid approaches to 
a lower level of physiologic range, appearing very low particularly for the 
younger patients. Periodic hematic dosages of vitamin C of unoperable 
and operated patients treated with large doses of ascorbic acid have 
shown a rapid increase of its blood concentration which frequently has 
been very over 1500 mg%, the higher level of normal range. These high 
vitamin hematic levels, generally constant during the time, appear useful 
in increasing the defense reactions of the cancerous patient [146].
SEVERE HYPOVITAMINOSIS C IN LUNG CANCER PATIENTS
The utilization of vitamin C in surgical repair and lymphocyte-related 
host resistance [147]: Plasma and buffy-coat vitamin C were estimated 
in 158 samples from 139 lung cancer patients, at all stages of the disease. 
Most samples showed hypovitaminosis C in both estimations: 64% had 
plasma, and 25% buffy-coat values below the thresholds for incipient 
clinical scurvy (0.3 mg% and 10 jg/108 cells, respectively). Levels were 
diet-dependent and could be increased by oral supplements. Levels 
were low both in tumor-bearing patients and in those clinically free of 
disease after resection. The latter had particularly low values during 
the first 6 months, indicating the utilization of vitamin C in surgical 
repair. The vitamin C content of 13 primary lung tumors was assayed: 
Tumors had higher vitamin C content (mean 1116+551, ug/g tissue) 
than normal lung (58.5 + 20-4, ug/g). Mononuclear cells from normal 
individuals show a higher vitamin C content than polymorphs, but in 
lung cancer patients, the expected correlation of buffy-coat vitamin C 
with the proportion of lymphocytes in peripheral blood was obscured 
by an inverse correlation in patients with relative lymphocytosis (25% 
lymphocytes), confirmed by an inverse correlation of the proportion 
of lymphocytes in peripheral blood with mononuclear-cell vitamin C 
in 14 patients in whom this was measured. These correlations were 
unaffected by controlling for plasma values and indicate the utilization 
of vitamin C in lymphocyte-related antitumor mechanisms. Vitamin C 
is necessary for phagocytosis and for the expression of cell-mediated 
immunity. In view of the increasing circumstantial evidence that 
immune mechanisms exert some measure of control on tumor extension 
and metastasis in man, the effect of supplementation with vitamin C in 
lung cancer patients on survival should be tested in a clinical trial.
The results, over several years this laboratory has measured plasma and 
Table 2: Comparison of the mean vitamin C values in normal individuals and patients with scurvy obtained in this laboratory with 
reports in the literature
Years Mean vitamin C values
This laboratory (numbers in parentheses) Literature
Buffy coat (Ug/108 cells) Plasma (mg %) Buffy coat (qtg/108 cells) Plasma (mg %) Number of studies*
<55 years 31.4 (46) 1.03 (31) 29.1 0.88 7
>65 years 25.6 (88) 0.45 (102) 20.8 0.45 13
Institutionalized 10.4 (142) 0.18 (246) 14.3 0.22 25
Scurvy 5.3 (5) 0.1 (5) 3.7 0.09 6
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leukocyte vitamin C in a number of population groups, many concurrent 
with this survey of lung cancer patients. Values in these populations agree 
well with the literature (Table 2) [148] and allow us to establish tentative 
thresholds below which plasma and leukocyte levels are associated with 
scurvy and hypovitaminosis C; a condition in which reduced vitamin C 
reserves may affect health though not leading to overt scurvy [148].
CONCLUSION
The current review studied that a role of vitamins such as C, E, and A in 
medicinal field, particularly in lung disease-lung cancer. Vitamin C plays 
a significant role in daily life, dietary system like eating food, vegetable 
and smoking of cigarette. It helps to prevent or stop the damage the 
lung tissue/or cause lung cancer. The study reported that the use of 
vitamin C act as antioxidant in diseases such as lung disease, i.e., role of 
vitamin C in lung cancer.
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